课题基金 / 基金详情

Molecular mechanisms of peritoneal dissemination of ovarian cancer cell, based on the analysis of its microenvironment

Molecular mechanisms of peritoneal dissemination of ovarian cancer cell, based on the analysis of its microenvironment
基于微环境分析的卵巢癌细胞腹腔播散的分子机制
批准号:
13470349
负责人:
KONISHI Ikuo
金额:
$9.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

KONISHI Ikuo的其他基金

相似基金

相关文献

中文摘要
翻译
卵巢癌是妇科癌症死亡的主要原因。卵巢癌患者预后不良与腹膜扩散有关,即癌细胞从原发灶脱落,附着于腹膜,并在原发部位重新生长的转移过程。本研究的目的是在分析癌细胞扩散的微环境的基础上,探讨卵巢癌细胞腹膜扩散的分子机制。通过对恶性腹水或卵巢肿瘤腹水的pH、pO2和pCO2的分析,揭示了卵巢癌细胞的缺氧环境。此外,免疫组织化学检测HIF-1α的表达和HIF-1α的表达表明,HIF-1α定位于乳头状突起周围的肿瘤细胞核中。这些发现表明卵巢癌细胞在腹膜扩散的最初阶段就暴露在低氧环境中。基因芯片分析表明,低氧…更多的a下调卵巢癌细胞中细胞黏附分子E-钙粘附素和β-连环素的表达。在卵巢癌组织中,HIF-1α阳性的肿瘤细胞倾向于E-钙粘蛋白表达缺失。Northern印迹和Western印迹分析还表明,缺氧通过上调E-钙粘蛋白转录抑制因子SNAL的表达,减弱了E-钙粘蛋白在卵巢癌细胞中的表达。因此,低氧微环境可能在肿瘤细胞的黏附减弱和向转移表型转化中起重要作用。我们对ras相关GTP酶Rho在卵巢上皮性肿瘤中的表达研究发现,与良性肿瘤相比,卵巢癌中ras相关GTP酶Rho的表达水平升高。此外,腹膜播散性癌组织中其在mRNA和蛋白水平的表达明显高于原发灶。溶血寡糖酸(LPA)上调和激活Rho可增加卵巢癌细胞的体外侵袭力,而Rho的特异性抑制剂C3胞外酶可逆转LPA的作用。裸鼠体外模型显示腹膜转移在组成性表达Rho的卵巢癌细胞中更为明显。这些发现表明,Rho的上调在卵巢癌的发生发展过程中起着至关重要的作用,并将成为未来治疗的分子靶点。较少
英文摘要
Ovarian carcinoma is the leading cause of gynecological cancer death. The poor prognosis for patients with ovarian cancer is related with peritoneal dissemination; a metastatic process in which cancer cells detach from the primary tumor, attach to the peritoneum, and re-grow at the site. The objective of this study is to explore the molecular mechanisms of peritoneal dissemination of ovarian cancer cells, based on the analysis of the microenvironment of disseminating cancer cells.Analysis of pH, pO2 and pCO2 of malignant ascitic or ovarian tumor fluids disclosed hypoxic environment of ovarian cancer cells. In addition, immunohistochemical study on the expression and hypoxia-inducible factor-1 alpha (HIF-1 alpha) showed that HIF-1 alpha is localized in the nuclei of tumor cells at the periphery of papillary projection. These findings indicate that ovarian cancer cells are exposed to hypoxia at the initial step of peritoneal dissemination.cDNA microarray analysis demonstrated that hypoxi … More a down-regulates the expression of cell adhesion molecules, E-cadherin and beta-catenin, in ovarian cancer cells. In ovarian carcinoma tissues, the tumor cells positive for HIF-1 alpha tended to lose E-cadherin expression. Northern blot and Western blot analyses also showed that hypoxia attenuates the expression of E-cadherin in ovarian cancer cells, via up-regulation of SNAL, a transcriptional represser of E-cadherin. Therefore, it is likely that hypoxic microenvironment plays an important role in the attenuation of cell adhesion and transformation into "metastatic phenotype" of cancer cells.Our study on the expression of ras-related GTPases Rho in epithelial ovarian tumors revealed that it was elevated in ovarian carcinomas compared with benign tumors. In addition, its expression at mRNA and protein levels was significantly higher in the peritoneal dissemination than in the primary lesion. Up-regulation and activation of Rho by treatment with lysophospahtidic acid (LPA) increased the in vitro invasiveness of ovarian cancer cells, and treatment with C3 exoenzyme, a specific inhibitor of Rho, reversed the effect of LPA treatment. Ex vivo model using nude mice showed that peritoneal dissemination was more prominent in ovarian cancer cells expressing Rho constitutively. These findings indicate that up-regulation of Rho is essential in the tumor progression of ovarian carcinoma, and will be a molecular target in the future therapy. Less
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
Tsuruta, Y., et al.: "Combination effect of adenovirus-mediated pro-apoptotic"European Journal of Cancer. 37. 531-541 (2001)
Tsuruta,Y.,等人:“腺病毒介导的促细胞凋亡的组合效应”欧洲癌症杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tsuruta Y., et al.: "Combination effect of adenoviral-mediated pro-apoptotic Bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines."Eur J Cancer. 37. 531-541 (2001)
Tsuruta Y.等人:“在卵巢癌细胞系中,腺病毒介导的促凋亡 Bax 基因转移与顺铂或紫杉醇治疗的组合效应。”Eur J Cancer。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Horiuchi A., et al.: "Toward understanding natural history of ovarian carcinoma development: a clinicopathological approach."Gynecol Oncol. (in press) (2003)
Horiuchi A. 等人:“了解卵巢癌发展的自然史:临床病理学方法。”Gynecol Oncol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Konishi I., et al.: "Gonadotropin hypothesis for development of epithelial ovarian carcinoma: a review."9th Biennial Meeting of IGCS. 113-116 (2002)
Konishi I. 等人:“上皮性卵巢癌发生的促性腺激素假说:综述。”IGCS 第九届双年度会议。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 16 条
    Develop of ovarian cancer stem cell specific immunotherapy based on DNA microarray analysis
    • 批准号:
      23659777
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      KONISHI Ikuo
    • 依托单位:
    Evolution of ovarian carcinoma cells through peritoneal dissemination ; genome-wide analysis and clinical application.
    • 批准号:
      21390452
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.32万
    • 财政年份:
      2009
    • 负责人:
      KONISHI Ikuo
    • 依托单位:
    Analysis of signaling pathways in peritoneal dissemination of ovarian cancer, which leads to investigation for their suppressor reagents.
    • 批准号:
      19390426
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2007
    • 负责人:
      KONISHI Ikuo
    • 依托单位:
    Development of a new molecular target therapy for ovarian carcinoma based on the analyses of mechanisms for its peritoneal dissemination
    • 批准号:
      15390502
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.82万
    • 财政年份:
      2003
    • 负责人:
      KONISHI Ikuo
    • 依托单位:
    海外基金